RU2008110498A - Комбинация снотворного средства и замещенного соединения бис арила и гетероарила и ее терапевтическое применение - Google Patents

Комбинация снотворного средства и замещенного соединения бис арила и гетероарила и ее терапевтическое применение Download PDF

Info

Publication number
RU2008110498A
RU2008110498A RU2008110498/04A RU2008110498A RU2008110498A RU 2008110498 A RU2008110498 A RU 2008110498A RU 2008110498/04 A RU2008110498/04 A RU 2008110498/04A RU 2008110498 A RU2008110498 A RU 2008110498A RU 2008110498 A RU2008110498 A RU 2008110498A
Authority
RU
Russia
Prior art keywords
alkyl
heteroaryl
formula
short
aryl
Prior art date
Application number
RU2008110498/04A
Other languages
English (en)
Russian (ru)
Inventor
Гэри Т. ЭММОНС (US)
Гэри Т. ЭММОНС
Сатхапана КОНГСАМУТ (US)
Сатхапана КОНГСАМУТ
Крейг Н. КАРСОН (US)
Крейг Н. КАРСОН
Коринн М. ЛЕГОФФ (US)
Коринн М. ЛЕГОФФ
Original Assignee
Авентис Фармасьютикалз Инк. (Us)
Авентис Фармасьютикалз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фармасьютикалз Инк. (Us), Авентис Фармасьютикалз Инк. filed Critical Авентис Фармасьютикалз Инк. (Us)
Publication of RU2008110498A publication Critical patent/RU2008110498A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
RU2008110498/04A 2005-08-19 2006-08-16 Комбинация снотворного средства и замещенного соединения бис арила и гетероарила и ее терапевтическое применение RU2008110498A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70965505P 2005-08-19 2005-08-19
US60/709,655 2005-08-19

Publications (1)

Publication Number Publication Date
RU2008110498A true RU2008110498A (ru) 2009-09-27

Family

ID=37772166

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008110498/04A RU2008110498A (ru) 2005-08-19 2006-08-16 Комбинация снотворного средства и замещенного соединения бис арила и гетероарила и ее терапевтическое применение

Country Status (17)

Country Link
US (1) US7618650B2 (cg-RX-API-DMAC7.html)
EP (1) EP1928442B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009504761A (cg-RX-API-DMAC7.html)
KR (1) KR20080038416A (cg-RX-API-DMAC7.html)
CN (1) CN101242819A (cg-RX-API-DMAC7.html)
AR (1) AR055609A1 (cg-RX-API-DMAC7.html)
AT (1) ATE447400T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006283703A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614943A2 (cg-RX-API-DMAC7.html)
CA (1) CA2617980A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006010219D1 (cg-RX-API-DMAC7.html)
ES (1) ES2336142T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008001778A (cg-RX-API-DMAC7.html)
RU (1) RU2008110498A (cg-RX-API-DMAC7.html)
SG (1) SG140147A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815009A (cg-RX-API-DMAC7.html)
WO (1) WO2007024600A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
WO2010045190A1 (en) 2008-10-15 2010-04-22 Boehringer Ingelheim International Gmbh Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102018681A (zh) * 2010-12-10 2011-04-20 荣港生技医药科技(北京)有限公司 一种美乐托宁缓释剂、其制备方法及其应用
US20130060052A1 (en) * 2011-01-17 2013-03-07 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CA2903394C (en) 2013-03-14 2021-08-31 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
JP7792730B2 (ja) * 2022-04-27 2025-12-26 杭州新元素▲薬▼▲業▼有限公司 尿酸を降下させるために使用できる化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726447B2 (en) * 1996-10-21 2000-11-09 Neurosearch A/S 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a

Also Published As

Publication number Publication date
EP1928442A2 (en) 2008-06-11
CA2617980A1 (en) 2007-03-01
ATE447400T1 (de) 2009-11-15
ES2336142T3 (es) 2010-04-08
MX2008001778A (es) 2008-04-07
US7618650B2 (en) 2009-11-17
SG140147A1 (en) 2008-03-28
US20080138413A1 (en) 2008-06-12
WO2007024600A2 (en) 2007-03-01
EP1928442B1 (en) 2009-11-04
CN101242819A (zh) 2008-08-13
TW200815009A (en) 2008-04-01
DE602006010219D1 (de) 2009-12-17
KR20080038416A (ko) 2008-05-06
AR055609A1 (es) 2007-08-29
AU2006283703A1 (en) 2007-03-01
BRPI0614943A2 (pt) 2011-04-26
JP2009504761A (ja) 2009-02-05
WO2007024600A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
RU2376292C2 (ru) Гамк-ергические модуляторы
JP6527534B2 (ja) ヒストンメチルトランスフェラーゼ及びdnaメチルトランスフェラーゼの二重阻害剤としての新規化合物
RU2008144584A (ru) 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний
JP2022506887A5 (cg-RX-API-DMAC7.html)
JP2013512903A5 (cg-RX-API-DMAC7.html)
RU2012127792A (ru) Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы
JP2005507938A5 (cg-RX-API-DMAC7.html)
RU2009105826A (ru) 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ
AR052903A1 (es) Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno.
CA2981499A1 (en) Methods of administering glutaminase inhibitors
RU2008126245A (ru) Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции
RU2007101685A (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
RU2015121043A (ru) Производные фенилэтилпиридина в качестве ингибиторов PDE-4
SK15432002A3 (sk) 2-acylindolové deriváty a ich použitie ako protinádorového prípravku
US12134602B2 (en) (−)-huperzine A processes and related compositions and methods of treatment
RU2007128926A (ru) Антагонисты 5ht7 рецепторов
JP2021514011A5 (cg-RX-API-DMAC7.html)
JP2009502953A5 (cg-RX-API-DMAC7.html)
RU2008143556A (ru) Производные тиазолилдигидроиндазола в качестве ингибиторов протеинкиназ
RU2005129550A (ru) Антагонисты рецептора ccr-3
RU2007124328A (ru) Замещенные птеридины для лечения воспалительных заболеваний
AR033430A1 (es) Derivados de alcoxicarbonilamino tetrazolil fenilo o acido alcoxicarbonilamino benzoico, su uso, un proceso para su preparacion y composiciones farmaceuticas que los comprenden
JP2009504761A5 (cg-RX-API-DMAC7.html)
RU2006104024A (ru) Каппа-агонисты, в особенности для лечения и/или профилактики синдрома раздраженной толстой кишки
CA2451238A1 (en) Cyclic diamine compound with 5 membered ring groups

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20100519